Hepatic schistosomiasis

被引:58
作者
Bica, I
Hamer, DH
Stadecker, MJ
机构
[1] Tufts Univ New England Med Ctr, Dept Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
关键词
D O I
10.1016/S0891-5520(05)70122-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Schistosomiasis is a major, worldwide cause of morbidity and mortality. Disease from the organism Schistosoma mansoni results from egg deposition in the liver, intestines, and other organs and is associated with an intense, granulomatous response from the human host. Clinical manifestations range from mild to severe intestinal forms, and hepatosplenic schistosomiasis, which is associated with hepatic fibrosis, portal hypertension, esophageal varices, and splenomegaly. This article presents information about the epidemiology, immunopathogenesis and clinical aspects of the disease, the relationship between hepatic schistosomiasis and viral infections, diagnosis, therapy, and control strategies for schistosomiasis.
引用
收藏
页码:583 / +
页数:23
相关论文
共 137 条
  • [31] DEELDER AM, 1994, TROP GEOGR MED, V46, P233
  • [32] RESISTANCE TO SCHISTOSOMA-MANSONI IN HUMANS - INFLUENCE OF THE IGE/IGG4 BALANCE AND IGG2 IN IMMUNITY TO REINFECTION AFTER CHEMOTHERAPY
    DEMEURE, CE
    RIHET, P
    ABEL, L
    OUATTARA, M
    BOURGOIS, A
    DESSEIN, AJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) : 1000 - 1008
  • [33] ENVIRONMENTAL, GENETIC AND IMMUNOLOGICAL FACTORS IN HUMAN RESISTANCE TO SCHISTOSOMA-MANSONI
    DESSEIN, AJ
    COUISSINIER, P
    DEMEURE, C
    RIHET, P
    KOHLSTAEDT, S
    CARNEIROCARVALHO, D
    OUATTARA, M
    GOUDOTCROZEL, V
    DESSEIN, H
    BOURGOIS, A
    ABEL, L
    CARVALLO, EM
    PRATA, A
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1992, 21 (05) : 423 - 453
  • [34] Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-γ receptor gene
    Dessein, AJ
    Hillaire, D
    Elwali, NEMA
    Marquet, S
    Mohamed-Ali, Q
    Mirghani, A
    Henri, S
    Abdelhameed, AA
    Saeed, OK
    Magzoub, MMA
    Abel, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) : 709 - 721
  • [35] ULTRASONOGRAPHICAL INVESTIGATION OF PERIPORTAL FIBROSIS IN CHILDREN WITH SCHISTOSOMA-MANSONI INFECTION - REVERSIBILITY OF MORBIDITY 23 MONTHS AFTER TREATMENT WITH PRAZIQUANTEL
    DOEHRINGSCHWERDTFEGER, E
    ABDELRAHIM, IM
    KARDORFF, R
    KAISER, C
    FRANKE, D
    SCHLAKE, J
    RICHTER, J
    ELSHEIKH, M
    MOHAMEDALI, Q
    EHRICH, JHH
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 46 (04) : 409 - 415
  • [36] IMMUNITY AFTER TREATMENT OF HUMAN SCHISTOSOMIASIS - ASSOCIATION BETWEEN IGE ANTIBODIES TO ADULT WORM ANTIGENS AND RESISTANCE TO REINFECTION
    DUNNE, DW
    BUTTERWORTH, AE
    FULFORD, AJC
    KARIUKI, HC
    LANGLEY, JG
    OUMA, JH
    CAPRON, A
    PIERCE, RJ
    STURROCK, RF
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) : 1483 - 1494
  • [37] HUMAN-ANTIBODY RESPONSES TO SCHISTOSOMA-MANSONI - THE INFLUENCE OF EPITOPES SHARED BETWEEN DIFFERENT LIFE-CYCLE STAGES ON THE RESPONSE TO THE SCHISTOSOMULUM
    DUNNE, DW
    GRABOWSKA, AM
    FULFORD, AJC
    BUTTERWORTH, AE
    STURROCK, RF
    KOECH, D
    OUMA, JH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) : 123 - 131
  • [38] Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment
    Dupré, L
    Hervé, M
    Schacht, AM
    Capron, A
    Riveau, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 454 - 463
  • [39] Schistosomiasis
    El-Garem, AA
    [J]. DIGESTION, 1998, 59 (05) : 589 - 605
  • [40] CLINICAL AND PHARMACOKINETIC STUDY OF PRAZIQUANTEL IN EGYPTIAN SCHISTOSOMIASIS PATIENTS WITH AND WITHOUT LIVER-CELL FAILURE
    ELGUINIADY, MA
    ELTOUNY, MA
    ABDELBARY, MA
    ABDELFATAH, SA
    METWALLY, A
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 51 (06) : 809 - 818